United States Vaccine Market Size

United States vaccines market is set to surpass US$ 21 Billion threshold by 2025.
“United States Vaccines Market 2015 – 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the United States vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for United States vaccines market. The report includes historic data from 2015 to 2017 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the United States vaccines market. The report also explores detailed analysis of top 21 vaccines market assessment in United States from 2015 to 2017 and forecasts to 2025. The report also details the latest information about the vaccines pricing trends and regulatory landscape in United States.
Additionally, the report includes assessment of promising vaccines in the clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States vaccines market.
The report concludes with the profiles of major players in the United States vaccines market. The key market players are evaluated on various parameters such as business overview, promising vaccines in the clinical development and recent development.
The major companies dominating this market for its products, services and continuous product developments are:
 
Pfizer, Merck, Sanofi Pasteur and GlaxoSmithKline(GSK)
Top 21 Vaccines Covered Under This Report Are:
 
Prevnar/Prevnar 13
Gardasil/Gardasil 9
Fluzone
Varivax
Menactra
Proquad
Pneumovax
FluLaval/Fluarix
Havrix/Twinrix/Engerix-B
MMR II
Adacel
Boostrix
Bexsero
Menveo
Trumenba
Shingrix
Pentacel
Recombivax HB
Rotateq
Rotarix
Pediarix/Infanrix
The Latest Industry Data Included in this Report:
United States Vaccines Market Size & Analysis (2015 – 2025)
United States Vaccines Market Share & Y-o-Y Growth (%), 2015 – 2025
United States Top 21 Vaccines Market Assessment & Opportunity (2015 – 2025)
United States Vaccines Pricing Trends & Analysis
United States Vaccines Regulatory System
Major Deals in United States Vaccines Market
Promising Vaccines in Clinical Development by Major Companies
Key Market Drivers and Inhibitors of the United States Vaccines Market
Major Companies Analysis
The answers to the following key questions can be found in the report:
What is the size of the United States vaccines market during 2015 -2025?
What will be the revenue generated by each vaccine during the forecast period?
Which major vaccine provides highest market share?
How are the overall market and vaccine type growing?
What are the key drivers and inhibitors in the current market?
What will be the impact of drivers and inhibitors in the future?
What are the various vaccines available in the United States?
How is the market predicted to develop in the future?
Who are the key players in this market space?

Pediatric Vaccines Market Research Report Analysis 2018 – 2025

United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccines development.
“Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 – 2025” provides a unique tool for evaluating the market, highlighting opportunities, supporting strategic and tactical decision–making. This report recognizes that in this rapidly–evolving and competitive environment, up–to–date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments and focuses on United States pediatric vaccines market. The report also provides clear insight into current and future developments of the United States pediatric vaccines market. Furthermore, this report provides a deep and thorough evaluation of the top 10 pediatric vaccines by disease indication. On the basis of disease indication, the top 10 pediatric vaccines provide an in-depth analysis of doses administered, number of children being vaccinated and market size. The research includes historic data from 2010 to 2017 and forecasts until 2025.
The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccines market.
The report concludes with the profiles of major players in the United States pediatric vaccines market. The key market players are evaluated on various parameters such as company overview, pediatric vaccines portfolios and latest development & trends of the pediatric vaccines market.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
• Sanofi Pasteur
• GlaxoSmithKline(GSK)
• Merck & Co.
• Pfizer Inc
• Grifols
Major Pediatric Vaccines (Disease Indication) Covered Under This Report Are:
• Diphtheria, Tetanus & Pertussis (DTap)
• Hepatitis A
• Varicella/Chicken Pox
• Pneumococcal
• Haemophilus Influenzae Type B (HIB)
• Polio
• Rotavirus
• Hepatitis B
• Influenza Pediatric
• Measles, Mumps & Rubella (MMR)
The Latest Industry Data Included in this Report:
• United States Pediatric Vaccines Market Size & Analysis ,2010 – 2025
• United States Pediatric Vaccines Market Share and Y–o–Y Growth (%),2010 – 2025
• United States Pediatric Vaccines Market by Disease Indication ,2010 – 2025
• 10 Pediatric Vaccines Doses Administered (Volume),2010 – 2025
• Number of Children Being Vaccinated (Volume)2010 – 2025
• 10 Pediatric Vaccines Market Size and Forecast(Value),2010 – 2025
• Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current
   Product Portfolios and Latest Recent Development and Trends
The Following Key Questions have been Addressed in the Report:
• What is the size of the United States pediatric vaccines market during 2010 -2025?
• How will each segment of the United States pediatric vaccines market grow
   during the forecast period and what will be the revenue generated
   by each of the segments by the end of 2025?
• Which major pediatric vaccines provides highest market share?
• How much number of children being vaccinated during 2010 – 2025?
• How are the overall market and segments types growing?
• What are the major market drivers and inhibitors in the United States pediatric vaccines market?
• Who are the key players in the United States pediatric vaccines market and
   what are their contributions?

United States Vaccine Market

United States vaccines market is set to surpass US$ 21 Billion threshold by 2025

United States Vaccines Market 2015 – 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts presents an in-depth assessment of the United States vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States vaccines market. The report includes historical data from 2015 to 2017 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the United States vaccines market. The report also explores detailed analysis of top 21 vaccines market assessment in the United States from 2015 to 2017 and forecasts to 2025. The report also details the latest information about the vaccines pricing trends and regulatory landscape in the United States.

Additionally, the report includes an assessment of promising vaccines in the clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States vaccines market.

The report concludes with the profiles of major players in the United States vaccines market. The key market players are evaluated on various parameters such as business overview, promising vaccines in clinical development and recent development.

The major companies dominating this market for its products, services, and continuous product developments are:

  • Pfizer
  • Merck
  • Sanofi Pasteur
  • GlaxoSmithKline (GSK)

Top 21 Vaccines Covered Under This Report Are:

  • Prevnar/Prevnar 13
  • Gardasil/Gardasil 9
  • Fluzone
  • Varivax
  • Menactra
  • Proquad
  • Pneumovax
  • FluLaval/Fluarix
  • Havrix/Twinrix/Engerix-B
  • MMR II
  • Adacel
  • Boostrix
  • Bexsero
  • Menveo
  • Trumenba
  • Shingrix
  • Pentacel
  • Recombivax HB
  • Rotateq
  • Rotarix
  • Pediarix/Infanrix

The Latest Industry Data Included in this Report:

  • United States Vaccines Market Size & Analysis (2015 – 2025)
  • The United States Vaccines Market Share & Y-o-Y Growth (%), 2015 – 2025
  • The United States Top 21 Vaccines Market Assessment & Opportunity (2015 – 2025)
  • United States Vaccines Pricing Trends & Analysis
  • United States Vaccines Regulatory System
  • Major Deals in United States Vaccines Market
  • Promising Vaccines in Clinical Development by Major Companies
  • Key Market Drivers and Inhibitors of the United States Vaccines Market
  • Major Companies Analysis

Key Topics Covered:

1. Executive Summary

2. United States Vaccines Market Size & Analysis (2015 – 2025)

3. United States Vaccines Market Share & Y-o-Y Growth (%), 2015 – 2025

4. Key Drivers and Inhibitors of the United States Vaccines Market

4.1 Market Drivers

4.2 Market Inhibitors

5. United States Top 21 Vaccines Market Assessment & Opportunity (Value), 2015 – 2025

5.1 Prevnar/Prevnar 13

5.2 Gardasil/Gardasil 9

5.3 Fluzone

5.4 Varivax

5.5 Menactra

5.6 Proquad

5.7 Pneumovax 23

5.8 Fluarix/FluLaval

5.9 Havrix/Twinrix/Engerix-B

5.10 M-M-R II

5.11 Adacel

5.12 Boostrix

5.13 Bexsero

5.14 Menveo

5.15 Trumenba

5.16 Shingrix

5.17 Pentacel

5.18 Recombivax HB

5.19 Rotateq

5.20 Rotarix

5.21 Pediarix/Infanrix

5.22 Other Vaccines

6. United States Vaccines Pricing Trends & Analysis

7. United States Vaccines Regulatory System

8. Major Deals in United States Vaccines Market

8.1 Merger & Acquisitions

8.2 Collaboration Deal

8.3 Licensing Agreement

8.4 Exclusive Agreement

8.5 Distribution Agreement

9. Key Companies Analysis

  • GlaxoSmithKline (GSK)
  • Merck
  • Pfizer
  • Sanofi Pasteur